​

Aardvark Therapeutics Ownership | Who Owns Aardvark Therapeutics?

OverviewFinancialsChart

Aardvark Therapeutics Ownership Summary

Aardvark Therapeutics is owned by 65.83% institutional investors, 24.03% insiders, and 10.14% retail investors.

AARD Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAardvark Therapeutics65.83%24.03%10.14%
SectorHealthcare Stocks 278.70%10.61%-189.31%
IndustryBiotech Stocks 63.84%10.66%25.50%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202527-8,686,452-65-27---
Jun 30, 20151-1---1---

Recent Insider Transactions

DateNameRoleActivityValue
Aug 17, 2007Creamer James W III CFO & TreasurerBuy$950.00
Nov 08, 2006Creamer James W III CFO & TreasurerBuy$165.00K
Oct 26, 2006Zimlich Joseph C-Buy$51.00K
Dec 06, 2006Zimlich Joseph C-Buy$73.52K
May 12, 2006Creamer James W III Chief Financial OfficerBuy$915.00

Insider Transactions Trends

DateBuySell
2025 Q2--
2007 Q31-
2007 Q1--
2006 Q43-
2006 Q21-

AARD Ownership FAQ

Who Owns Aardvark Therapeutics?

Aardvark Therapeutics shareholders are primarily institutional investors at 65.83%, followed by 24.03% insiders and 10.14% retail investors. The average institutional ownership in Aardvark Therapeutics's industry, Biotech Stocks , is 63.84%, which Aardvark Therapeutics exceeds.

Does Blackrock own Aardvark Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Aardvark Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools